Lirio Covey, PhD
Professor of Clinical Psychology (in Psychiatry)
Lirio Covey's current research activities focus on the relationship between smoking, smoking cessation, suicide related outcomes, depression, anxiety, and ADHD. She is also associated with NIDA's Clinical Trial Network and the Substance Abuse Division of NYSPI.
Dr. Covey's research is focused on nicotine dependence, its comorbidity with psychiatric illnesses in particular depression, attention deficit hyperactivity disorder, alcohol dependence, and development of smoking cessation treatments.
Dr. Covey and colleagues are conducting research on: the association between smoking cessation, depression and suicide; smoking cessation and attention deficit hyperactivity disorder; race/ethnicity differences in treatment response to various smoking cessation medications, including bupropion, nicotine patch, and methylphenidate.
- Nicotine Dependence Treatment
- Psychiatric Epidemiology
Covey LS, Berlin I, Hu M, Hake JK: Smoking and suicidal behaviors in a sample of US adults with low mood: a retrospective analysis of longitudinal data. British Medical Journal Open 2012;2: 2012-000876
Covey LS, Glassman AH, Jiang H, Fried J, Masmela J, LoDuca C, Petkova E, Rodriguez K. : A maintenance trial of bupropion and/or nicotine gum for the prevention of smoking relapse. Addiction 2007;102: 1292-1302
Covey LS, Botello-Harbuam M, Glassman AH, Fried J, Masmela J, LoDuca C, Salzman V. : Smokers’ response to combination bupropion, nicotine patch, and counseling treatment by race/ethnicity. Ethnicity and Disease 008
Seidman DF, Covey LS (Eds): Helping the Hard-Core Smoker: A Clinician's Guide, Lawrence Erlbaum Press, Englewood, NJ, U.S.A., 1999
Covey LS, Hu MC, Winhusen T, Weissman J, Berlin I, Nunes EV.: OROS-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: Racial/ethnic differences. Drug and Alcohol Dependence 2010